Literature DB >> 19898975

Visfatin induces oxidative stress in differentiated C2C12 myotubes in an Akt- and MAPK-independent, NFkB-dependent manner.

Radu C Oita1, Dudley Ferdinando, Steve Wilson, Christopher Bunce, Dawn J Mazzatti.   

Abstract

Adipose tissue is an important endocrine and metabolic tissue that is actively involved in cross-talk with peripheral organs such as skeletal muscle. It is likely that adipose-derived factors may underlie the development of insulin resistance in muscle. Thus, the cross-talk between adipose and muscle may be important for the propagation of obesity-related diseases. Visfatin (Pre-B-cell colony-enhancing factor 1 homolog/Nampt) is a recently discovered adipokine with pleiotropic functions. The aim of this study was to examine the effect of visfatin on cellular stress responses and signalling pathways in skeletal muscle. Visfatin treatment of differentiated C2C12 myotubes generated reactive oxygen species (ROS) comprising both superoxide and hydrogen peroxide that was dependent on de novo transcription and translation. In differentiated C2C12 myoblasts, visfatin had no effects on insulin-stimulated Akt phosphorylation nor on activation of the Akt signalling pathway. Additionally, visfatin-induced oxidative stress occurred independent of activation of the stress-activated protein kinases (MAPKs) ERK and p38. In contrast, phosphorylation of NFkB was associated with visfatin-mediated generation of ROS and blockade of this pathway via selective IKK inhibition led to a partial reduction in oxidative stress. Furthermore, the generation of ROS following visfatin treatment was highly dependent on both de novo transcription and translation. Taken together, these findings provide novel insights for the unique pathophysiological role of visfatin in skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19898975     DOI: 10.1007/s00424-009-0752-1

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  59 in total

Review 1.  Generalized lipodystrophy, congenital and acquired (lipoatrophy).

Authors:  M Seip; O Trygstad
Journal:  Acta Paediatr Suppl       Date:  1996-06

2.  Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors.

Authors:  Daniela Dietze-Schroeder; Henrike Sell; Mathias Uhlig; Marlis Koenen; Jürgen Eckel
Journal:  Diabetes       Date:  2005-07       Impact factor: 9.461

Review 3.  Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders.

Authors:  B Viollet; R Mounier; J Leclerc; A Yazigi; M Foretz; F Andreelli
Journal:  Diabetes Metab       Date:  2007-11-07       Impact factor: 6.041

Review 4.  Adipokines, inflammation, and the endothelium in diabetes.

Authors:  Waleed Aldhahi; Osama Hamdy
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

5.  Involvement of dimethylarginine dimethylaminohydrolase-2 in visfatin-enhanced angiogenic function of endothelial cells.

Authors:  Jian Xiao; Zheng-Jun Xiao; Zhen-Guo Liu; Huan-Yu Gong; Qiong Yuan; Shan Wang; Yuan-Jian Li; De-Jian Jiang
Journal:  Diabetes Metab Res Rev       Date:  2009-03       Impact factor: 4.876

Review 6.  Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes.

Authors:  M Lorenzo; S Fernández-Veledo; R Vila-Bedmar; L Garcia-Guerra; C De Alvaro; I Nieto-Vazquez
Journal:  J Anim Sci       Date:  2007-10-16       Impact factor: 3.159

7.  Ethanol-induced oxidative stress is mediated by p38 MAPK pathway in mouse hippocampal cells.

Authors:  Bo Mi Ku; Yeon Kyung Lee; Joo Yeon Jeong; Jihye Mun; Jae Yoon Han; Gu Seob Roh; Hyun Joon Kim; Gyeong Jae Cho; Wan Sung Choi; Gwan-su Yi; Sang Soo Kang
Journal:  Neurosci Lett       Date:  2007-03-28       Impact factor: 3.046

8.  Pre-B-cell colony-enhancing factor gene polymorphisms and risk of acute respiratory distress syndrome.

Authors:  Ednan K Bajwa; Chu-Ling Yu; Michelle N Gong; B Taylor Thompson; David C Christiani
Journal:  Crit Care Med       Date:  2007-05       Impact factor: 7.598

9.  Visfatin stimulates production of monocyte chemotactic protein-1 and interleukin-6 in human vein umbilical endothelial cells.

Authors:  S W Liu; S B Qiao; J S Yuan; D Q Liu
Journal:  Horm Metab Res       Date:  2008-11-13       Impact factor: 2.936

10.  The novel adipocytokine visfatin exerts direct cardioprotective effects.

Authors:  Shiang Y Lim; Sean M Davidson; Ajeev J Paramanathan; Christopher C T Smith; Derek M Yellon; Derek J Hausenloy
Journal:  J Cell Mol Med       Date:  2008-04-08       Impact factor: 5.310

View more
  15 in total

1.  Nicotinamide Phosphoribosyltransferase Promotes Pulmonary Vascular Remodeling and Is a Therapeutic Target in Pulmonary Arterial Hypertension.

Authors:  Jiwang Chen; Justin R Sysol; Sunit Singla; Shuangping Zhao; Aya Yamamura; Daniela Valdez-Jasso; Taimur Abbasi; Krystyna M Shioura; Sakshi Sahni; Vamsi Reddy; Arvind Sridhar; Hui Gao; Jaime Torres; Sara M Camp; Haiyang Tang; Shui Q Ye; Suzy Comhair; Raed Dweik; Paul Hassoun; Jason X-J Yuan; Joe G N Garcia; Roberto F Machado
Journal:  Circulation       Date:  2017-02-15       Impact factor: 29.690

2.  Novel Mechanism for Nicotinamide Phosphoribosyltransferase Inhibition of TNF-α-mediated Apoptosis in Human Lung Endothelial Cells.

Authors:  Radu C Oita; Sara M Camp; Wenli Ma; Ermelinda Ceco; Mark Harbeck; Patrick Singleton; Joe Messana; Xiaoguang Sun; Ting Wang; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2018-07       Impact factor: 6.914

3.  Visfatin: New marker of oxidative stress in preterm newborns.

Authors:  Lucia Marseglia; Gabriella D'Angelo; Marta Manti; Salvatore Aversa; Chiara Fiamingo; Teresa Arrigo; Ignazio Barberi; Carmelo Mamì; Eloisa Gitto
Journal:  Int J Immunopathol Pharmacol       Date:  2015-11-02       Impact factor: 3.219

4.  Increased visfatin expression is associated with nuclear factor-kappa B and phosphatidylinositol 3-kinase in periodontal inflammation.

Authors:  Erkan Özcan; N Işıl Saygun; Rahşan Ilıkçı; Yıldırım Karslıoğlu; Uğur Muşabak; Sait Yeşillik
Journal:  Clin Oral Investig       Date:  2016-06-09       Impact factor: 3.573

5.  Visfatin mediates doxorubicin resistance in human non-small-cell lung cancer via Akt-mediated up-regulation of ABCC1.

Authors:  Zhili Cao; Naixin Liang; Huaxia Yang; Shanqing Li
Journal:  Cell Prolif       Date:  2017-08-01       Impact factor: 6.831

6.  Secretion of one adipokine Nampt/Visfatin suppresses the inflammatory stress-induced NF-κB activity and affects Nampt-dependent cell viability in Huh-7 cells.

Authors:  Yi-Ching Lin; Hui-Chung Wu; Chen-Chung Liao; Yi-Chih Chou; Shwu-Fen Pan; Chi-Ming Chiu
Journal:  Mediators Inflamm       Date:  2015-02-26       Impact factor: 4.711

7.  Expression of nicotinamide phosphoribosyltransferase-influenced genes predicts recurrence-free survival in lung and breast cancers.

Authors:  Tong Zhou; Ting Wang; Joe G N Garcia
Journal:  Sci Rep       Date:  2014-08-22       Impact factor: 4.379

8.  Nicotinamide phosphoribosyltransferase may be involved in age-related brain diseases.

Authors:  Li-Ying Liu; Feng Wang; Xia-Yan Zhang; Peng Huang; Yun-Bi Lu; Er-Qing Wei; Wei-Ping Zhang
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

9.  Visfatin induces MUC8 and MUC5B expression via p38 MAPK/ROS/NF-κB in human airway epithelial cells.

Authors:  Si-Youn Song; Eun Chae Jung; Chang Hoon Bae; Yoon Seok Choi; Yong-Dae Kim
Journal:  J Biomed Sci       Date:  2014-05-20       Impact factor: 8.410

10.  Monomeric eNAMPT in the development of experimental diabetes in mice: a potential target for type 2 diabetes treatment.

Authors:  Julius Kieswich; Sophie R Sayers; Marta F Silvestre; Steven M Harwood; Muhammad M Yaqoob; Paul W Caton
Journal:  Diabetologia       Date:  2016-08-19       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.